...
首页> 外文期刊>British Microbiology Research Journal >Antibiotic Susceptibility Test of Klebsiella pneumoniae and K. oxytoca Isolated from Different Clinical Samples and Perform Random Amplified Polymorphic DNA among K. pneumoniae
【24h】

Antibiotic Susceptibility Test of Klebsiella pneumoniae and K. oxytoca Isolated from Different Clinical Samples and Perform Random Amplified Polymorphic DNA among K. pneumoniae

机译:来自不同临床样品中肺炎肺炎的抗生素敏感性试验和催津催产药中的催产,在K.Pneumoniae中进行随机扩增的多态性DNA

获取原文

摘要

Aims:?To study the prevalence of MDR and ESBL producing?Klebsiella pneumoniae?and?Klebsiella oxytocaand perform RAPD (Random amplified polymorphic DNA) by optimizing PCR among isolated ESBL producing?Klebsiella pneumoniae.Place and Duration of Study:?This study was done to assess the prevalence of MDR and ESBL producing?Klebsiella pneumoniae?and?K. oxytoca?in urine, pus and sputum from March 2013 to April 2014 at KIST Medical College and PCR was performed at Nepal Academy of Science and Technology upto March, 2015.Methodology:?K. pneumoniae?and?K. oxytoca?were isolated from urine, pus and sputum samples from KIST Medical College, Lalitpur, Nepal. Antibiotic susceptibility test was performed by using disk diffusion method. MDR isolates which were suspected as ESBL producers were confirmed by using double disk diffusion test and combined disk diffusion test for same isolates. Chromosomal DNA was isolated from ESBL producing?K. pneumoniae. PCR was optimized by varying different reagents and visualized using gel electrophorosis. Under optimized condition chromosomal DNA was amplified, gel electrophoresis was performed and polymorphism was detected.Results:?The drug resistance pattern of?K. oxytoca?was high as compared to?K. pneumoniae. In urine, pus and sputum samples the growth of both organisms was very much low i.e. 2.5% among total samples. 90% of?K. pneumoniae?isolated from urine were ESBL producers whereas only 42.85% of?K. pneumoniae?from pus and sputum were ESBL producers.?K. oxytoca?isolated from all samples were MDR as well as ESBL producers. Chromosomal DNA analysis of different antibiotic resistance pattern among?K. pneumoniaeshowed higher the drug resistance lowers the polymorphism.Conclusions:?This study showed that higher the drug resistance lesser the polymorphism and greater the adaptability towards used antibiotics by production of antibiotic hydrolyzing enzymes. So, further study is required for the determination of polymorphism and drug resistance pattern correlation with organisms' adaptability to validate this concept.
机译:目的:研究MDR和ESBL生产的患病率?Klebsiella肺炎?和?Klebsiella oxytocaand通过优化孤立的ESBL中的PCR来进行RAPD(随机扩增的多晶型DNA),在孤立的ESBL生产中进行PCR,克莱布拉肺炎.Place和学习持续时间:?这项研究完成了评估MDR和ESBL生产的患病率?Klebsiella肺炎?和?k。催津毒素?在尿液中,2013年3月至2014年4月在KIST医学院和PCR在2015年3月的尼泊尔科学学院进行了PCR,从2015年3月进行了PCR。方法:?K。肺炎?和?k。催产症患者来自尼泊尔康师医学院的尿,脓和痰样品中分离出来。通过使用盘扩散法进行抗生素敏感性测试。通过使用双盘扩散试验和相同的分离物的组合盘扩散试验来确认怀疑作为ESBL生产商的MDR分离物。从ESBL产生染色体DNA产生βK。肺炎。通过改变不同的试剂并使用凝胶电泳来可视化优化PCR。在优化的条件下,扩增条件染色体DNA,进行凝胶电泳,检测多态性。结果:αβK的耐药图案。催产症?与βk相比,高。肺炎。在尿液中,脓液和痰液样本两种生物的生长非常低,即总样品中的2.5%。 90%的?k。肺炎?从尿液中分离是ESBL生产商,而只有42.85%的?K。肺炎?来自脓脓和痰是ESBL生产者。催津毒素?与所有样品分离的是MDR以及ESBL生产商。不同抗生素抗性模式的染色体DNA分析?K.肺炎源较高的耐药性降低了多态性。结论:本研究表明,通过生产抗生素水解酶,耐药性较小,耐药性较高,对使用抗生素的适应性较高。因此,需要进一步研究,用于测定与生物体的适应性验证这一概念的多态性和耐药模式相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号